$TNXP

$5.39 +$0.09 (1.7%) Close

$TNXP Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 17.2M shares outstanding

Who owns TNXP?

By type of holder

Institutions 53.9% Insiders 0.0% Everyone else 46.1%

Concentration Top 10 holders own 39.6%

BlackRock, Inc. 8.2% · Point72 Asset Management, L.P. 6.8%

Institutional ownership

53.9%

+25.5 pts vs last qtr

Institutional holders

100

+19 vs last qtr

Net shares bought

+4.4M

by institutions in Q2 2026

New / sold out

27 / 8

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Point72 Asset Management, L.P. +1.0M
Millennium Management LLC +747.3K

Biggest sellers in Q2 2026

Citadel Advisors LLC −272.9K
Balyasny Asset Management L.P. −180.5K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Tonix Pharmaceuticals Holding Corp. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025

+107298.3%

+3177.17% a year

Each share's claim on the business

−99.9%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$27.7M vs $20.1M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years20% 1–3 years32% Under 1 year48%

Quarterly turnover

55.6%

of institutional shares changed hands

Top 10 managers, median time held

1.5 years

Super Investors

Investment managers reporting TNXP on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B BlackRock, Inc.	1.4M	8.15%	+429.9K (+44.4%)	2023	0.0%
Shares held by quarter Peak holding5.9M (Q4'24) Change over 8 quarters+1.4M Share of the company8.150% BlackRock, Inc.'s full portfolio →
PA Point72 Asset Management, L.P.	1.2M	6.80%	+1.0M (+830.3%)	Q4 '25	0.0%
Shares held by quarter Peak holding1.6M (Q4'24) Change over 8 quarters+1.2M Share of the company6.800% Point72 Asset Management, L.P.'s full portfolio →

BlackRock, Inc.

1.4M

% of company

8.15%

Change vs last qtr

+429.9K (+44.4%)

Held since

2023

Point72 Asset Management, L.P.

1.2M

% of company

6.80%

Change vs last qtr

+1.0M (+830.3%)

Held since

Q4 '25

28 more super investors behind a free account

See every manager holding Tonix Pharmaceuticals Holding Corp., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting TNXP on Form N-PORT; together they hold 13.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$6.23M	488.1K	2.85%	0.00%	June 30, 2026
IR iShares Russell 2000 ETF iShares Trust	$4.98M	389.9K	2.27%	0.01%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$6.23M

% of company

2.85%

% of the fund

0.00%

As of

June 30, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$4.98M

% of company

2.27%

% of the fund

0.01%

As of

June 30, 2026

23 more funds behind a free account

See every fund holding Tonix Pharmaceuticals Holding Corp. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
LS Lederman Seth Insider	881	0.01%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.010% Lederman Seth's insider activity →
SG Sullivan Gregory M Insider	70	0.00%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company0.000% Sullivan Gregory M's insider activity →

Lederman Seth

Insider

881

% of company

0.01%

Change vs last qtr

—

Held since

—

Sullivan Gregory M

Insider

% of company

0.00%

Change vs last qtr

—

Held since

—

2 more holders behind a free account

See every insider and 5%+ holder of Tonix Pharmaceuticals Holding Corp..

Comments